Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1161-1170 of 2859 for cancer

Edit search filters
  1. A Phase I, Multi-Center, Open Label, Dose De-escalation And Expansion Study Of Gemcitabine And Cisplatin With AG120 Or Pemigatinib For Advanced Cholangiocarcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study Of Ovarian Tissue Freezing For The Preservation Of Fertility In Children

    Rochester, MN

  3. Comparing The Addition Of Radiation Either Before Or After Surgery For Patients With Brain Metastases

    Jacksonville, FL

  4. A Study to Assess AC220 Given in Combination with Induction and Consolidation Therapy for Newly Diagnosed Acute Myeloid Leukemia (AML)

    Jacksonville, FL

  5. A Trial To Find And Investigate A Safe Dose Of BI 836858 In Combination With Decitabine For Patients With Acute Myeloid Leukemia (AML)

    Jacksonville, FL

  6. Study Of [68Ga]FAPI-46 PET In Patients With Pancreatic Ductal Carcinoma

    Rochester, MN

  7. Study To Evaluate Chemoembolization Combined With Durvalumab And Bevacizumab Therapy In Patients With Locoregional Hepatocellular Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of Atezolizumab As Adjuvant Therapy In Participants With Renal Cell Carcinoma (RCC) At High Risk Of Developing Metastasis Following Nephrectomy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. S1211, Bortezomib, Dexamethasone, And Lenalidomide With Or Without Elotuzumab In Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  10. Abemaciclib Versus Placebo In Patients With Advanced Dedifferentiated Liposarcoma

    Jacksonville, FL

.

Mayo Clinic Footer